These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25579870)

  • 21. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis.
    Yuhara H; Ogawa M; Kawaguchi Y; Igarashi M; Shimosegawa T; Mine T
    J Gastroenterol; 2014 Mar; 49(3):388-99. PubMed ID: 23720090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
    Wan J; Ren Y; Zhu Z; Xia L; Lu N
    BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: A network meta-analysis.
    Shou-Xin Y; Shuai H; Fan-Guo K; Xing-Yuan D; Jia-Guo H; Tao P; Lin Q; Yan-Sheng S; Ting-Ting Y; Jing Z; Fang L; Hao-Liang Q; Man L
    Medicine (Baltimore); 2020 Oct; 99(42):e22672. PubMed ID: 33080710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
    Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
    Lua GW; Muthukaruppan R; Menon J
    Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Sun HL; Han B; Zhai HP; Cheng XH; Ma K
    Surgeon; 2014 Jun; 12(3):141-7. PubMed ID: 24332479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
    Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis.
    Lyu Y; Wang B; Cheng Y; Xu Y; Du W
    Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):426-432. PubMed ID: 31490455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.
    Inamdar S; Han D; Passi M; Sejpal DV; Trindade AJ
    Gastrointest Endosc; 2017 Jan; 85(1):67-75. PubMed ID: 27612923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A More Focused Approach to Pharmacoprevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Gardner TB
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1240-1. PubMed ID: 25737441
    [No Abstract]   [Full Text] [Related]  

  • 32. Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis.
    Yaghoobi M; Rolland S; Waschke KA; McNabb-Baltar J; Martel M; Bijarchi R; Szego P; Barkun AN
    Aliment Pharmacol Ther; 2013 Nov; 38(9):995-1001. PubMed ID: 24099466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
    Tomoda T; Kato H; Ueki T; Akimoto Y; Hata H; Fujii M; Harada R; Ogawa T; Wato M; Takatani M; Matsubara M; Kawai Y; Okada H
    Gastroenterology; 2019 May; 156(6):1753-1760.e1. PubMed ID: 30772342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination Topical Epinephrine and Non-steroidal Inflammatory Drugs in the Prevention of Post-ERCP Pancreatitis: A Systematic Review.
    El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Issak A; Choi AY; Moosvi Z; Chang KJ; Samarasena JB
    Dig Dis Sci; 2023 Mar; 68(3):957-968. PubMed ID: 35695971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Where Do We Stand Now?
    Ahmad W; Okam NA; Torrilus C; Rana D; Khatun MK; Jahan N
    Cureus; 2020 Aug; 12(8):e10115. PubMed ID: 33005532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
    Chiu YJ; Chen SC; Kang YN; Hou SK; Chao CC; Chang CC
    J Formos Med Assoc; 2021 Apr; 120(4):1090-1099. PubMed ID: 33183879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials.
    Yu G; Li S; Wan R; Wang X; Hu G
    Pancreas; 2015 May; 44(4):561-9. PubMed ID: 25822153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.